Literature DB >> 26743478

Genomic copy number analysis of a spectrum of blue nevi identifies recurrent aberrations of entire chromosomal arms in melanoma ex blue nevus.

May P Chan1,2, Aleodor A Andea1,2, Paul W Harms1,2, Alison B Durham2, Rajiv M Patel1,2, Min Wang1, Patrick Robichaud2, Gary J Fisher2, Timothy M Johnson2, Douglas R Fullen1,2.   

Abstract

Blue nevi may display significant atypia or undergo malignant transformation. Morphologic diagnosis of this spectrum of lesions is notoriously difficult, and molecular tools are increasingly used to improve diagnostic accuracy. We studied copy number aberrations in a cohort of cellular blue nevi, atypical cellular blue nevi, and melanomas ex blue nevi using Affymetrix's OncoScan platform. Cases with sufficient DNA were analyzed for GNAQ, GNA11, and HRAS mutations. Copy number aberrations were detected in 0 of 5 (0%) cellular blue nevi, 3 of 12 (25%) atypical cellular blue nevi, and 6 of 9 (67%) melanomas ex blue nevi. None of the atypical cellular blue nevi displayed more than one aberration, whereas complex aberrations involving four or more regions were seen exclusively in melanomas ex blue nevi. Gains and losses of entire chromosomal arms were identified in four of five melanomas ex blue nevi with copy number aberrations. In particular, gains of 1q, 4p, 6p, and 8q, and losses of 1p and 4q were each found in at least two melanomas. Whole chromosome aberrations were also common, and represented the sole finding in one atypical cellular blue nevus. When seen in melanomas, however, whole chromosome aberrations were invariably accompanied by partial aberrations of other chromosomes. Three melanomas ex blue nevi harbored aberrations, which were absent or negligible in their precursor components, suggesting progression in tumor biology. Gene mutations involving GNAQ and GNA11 were each detected in two of eight melanomas ex blue nevi. In conclusion, copy number aberrations are more common and often complex in melanomas ex blue nevi compared with cellular and atypical cellular blue nevi. Identification of recurrent gains and losses of entire chromosomal arms in melanomas ex blue nevi suggests that development of new probes targeting these regions may improve detection and risk stratification of these lesions.

Entities:  

Mesh:

Year:  2016        PMID: 26743478     DOI: 10.1038/modpathol.2015.153

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  42 in total

1.  Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas.

Authors:  J S Smith; A Perry; T J Borell; H K Lee; J O'Fallon; S M Hosek; D Kimmel; A Yates; P C Burger; B W Scheithauer; R B Jenkins
Journal:  J Clin Oncol       Date:  2000-02       Impact factor: 44.544

2.  Identification of HRAS mutations and absence of GNAQ or GNA11 mutations in deep penetrating nevi.

Authors:  Ryan P Bender; Matthew J McGinniss; Paula Esmay; Elsa F Velazquez; Julie Dr Reimann
Journal:  Mod Pathol       Date:  2013-04-19       Impact factor: 7.842

3.  Cellular blue nevus. Clinicopathologic study of forty-five cases.

Authors:  H A Rodriguez; L V Ackerman
Journal:  Cancer       Date:  1968-03       Impact factor: 6.860

4.  Discrete breakpoint mapping and shortest region of overlap of chromosome arm 1q gain and 1p loss in human hepatocellular carcinoma detected by semiquantitative microsatellite analysis.

Authors:  Takafumi Nishimura; Naoshi Nishida; Teruaki Itoh; Toshiki Komeda; Yoshihiro Fukuda; Iwao Ikai; Yoshio Yamaoka; Kazuwa Nakao
Journal:  Genes Chromosomes Cancer       Date:  2005-01       Impact factor: 5.006

5.  Benign and malignant cellular blue nevus. A clinicopathological study of 30 cases.

Authors:  C R Temple-Camp; N Saxe; H King
Journal:  Am J Dermatopathol       Date:  1988-08       Impact factor: 1.533

6.  Cellular blue nevus with atypia (atypical cellular blue nevus): a clinicopathologic study of nine cases.

Authors:  T A Tran; J A Carlson; P C Basaca; M C Mihm
Journal:  J Cutan Pathol       Date:  1998-05       Impact factor: 1.587

7.  So-called "malignant blue nevus": a clinicopathologic study of 23 patients.

Authors:  Richard C W Martin; Rajmohan Murali; Richard A Scolyer; Patrick Fitzgerald; Marjorie H Colman; John F Thompson
Journal:  Cancer       Date:  2009-07-01       Impact factor: 6.860

8.  Proliferative activity, chromosomal aberrations, and tumor-specific mutations in the differential diagnosis between blue nevi and melanoma.

Authors:  Laura Held; Thomas K Eigentler; Gisela Metzler; Ulrike Leiter; Jane L Messina; L Frank Glass; Claus Garbe; Jürgen Bauer
Journal:  Am J Pathol       Date:  2012-12-21       Impact factor: 4.307

9.  Distinct chromosomal aberrations in sinonasal mucosal melanoma as detected by comparative genomic hybridization.

Authors:  Marcory van Dijk; Sandra Sprenger; Paul Rombout; Henri Marres; Johannes Kaanders; Judith Jeuken; Dirk Ruiter
Journal:  Genes Chromosomes Cancer       Date:  2003-02       Impact factor: 5.006

10.  High quality copy number and genotype data from FFPE samples using Molecular Inversion Probe (MIP) microarrays.

Authors:  Yuker Wang; Victoria E H Carlton; George Karlin-Neumann; Ronald Sapolsky; Li Zhang; Martin Moorhead; Zhigang C Wang; Andrea L Richardson; Robert Warren; Axel Walther; Melissa Bondy; Aysegul Sahin; Ralf Krahe; Musaffe Tuna; Patricia A Thompson; Paul T Spellman; Joe W Gray; Gordon B Mills; Malek Faham
Journal:  BMC Med Genomics       Date:  2009-02-19       Impact factor: 3.063

View more
  5 in total

Review 1.  Through the looking glass and what you find there: making sense of comparative genomic hybridization and fluorescence in situ hybridization for melanoma diagnosis.

Authors:  Jayson Miedema; Aleodor A Andea
Journal:  Mod Pathol       Date:  2020-02-17       Impact factor: 7.842

Review 2.  Biologically distinct subsets of nevi.

Authors:  Tova Rogers; Maria L Marino; Patricia Raciti; Manu Jain; Klaus J Busam; Michael A Marchetti; Ashfaq A Marghoob
Journal:  G Ital Dermatol Venereol       Date:  2016-04-27       Impact factor: 2.011

Review 3.  Melanoma Ex Blue Nevus With GNA11 Mutation and BAP1 Loss: Case Report and Review of the Literature.

Authors:  Li-Wei Chang; Viktoryia Kazlouskaya; Rashek Kazi; Diwakar Davar; Robert L Ferris; Jonhan Ho; Arivarasan Karunamurthy; Jaroslaw J Jedrych; Yuri L Bunimovich
Journal:  Am J Dermatopathol       Date:  2020-11       Impact factor: 1.319

Review 4.  Genomic and Transcriptomic Underpinnings of Melanoma Genesis, Progression, and Metastasis.

Authors:  Olga S Cherepakhin; Zsolt B Argenyi; Ata S Moshiri
Journal:  Cancers (Basel)       Date:  2021-12-28       Impact factor: 6.639

5.  Genome-wide copy number variations as molecular diagnostic tool for cutaneous intermediate melanocytic lesions: a systematic review and individual patient data meta-analysis.

Authors:  Chiel F Ebbelaar; Anne M L Jansen; Lourens T Bloem; Willeke A M Blokx
Journal:  Virchows Arch       Date:  2021-04-13       Impact factor: 4.064

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.